Tapewire

Nasdaq · USD

EHTH

eHealth, Inc.

Export transactions ↓
Tapewire entity
497
SEC CIK
0001333493
Parsed reports
537

Last 12 months

Inside the activity.

2 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202610
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202601
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 24, 2019 Filed Aug 27, 2019 21:37 UTC
Francis David K.Chief Operating Officer
Tax withholdingCommon Stock 415 $95.94 $39,815.10
Disclosure

SEC source: 0001333493-19-000140 · wf-form4_156694182397857.xml · nonDerivative · entry 1

Francis David K. · CIK 0001679661 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,603

F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 23, 2019 Filed Aug 23, 2019 20:55 UTC SaleCommon Stock 800 $102.00 $81,600.00
Disclosure

SEC source: 0001333493-19-000135 · wf-form4_156659369171579.xml · nonDerivative · entry 5

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,189

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 23, 2019 Filed Aug 23, 2019 20:55 UTC SaleCommon Stock 900 $97.96 $88,168.23
Disclosure

SEC source: 0001333493-19-000135 · wf-form4_156659369171579.xml · nonDerivative · entry 4

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,989

F5 · price: The price reported in Table I, Column 4 for sales on 8/23/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.61 to $98.49, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 23, 2019 Filed Aug 23, 2019 20:55 UTC SaleCommon Stock 9,404 $97.16 $913,717.09
Disclosure

SEC source: 0001333493-19-000135 · wf-form4_156659369171579.xml · nonDerivative · entry 3

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,889

F4 · price: The price reported in Table I, Column 4 for sales on 8/23/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.61 to $97.60, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 22, 2019 Filed Aug 23, 2019 20:55 UTC SaleCommon Stock 7,013 $102.15 $716,359.72
Disclosure

SEC source: 0001333493-19-000135 · wf-form4_156659369171579.xml · nonDerivative · entry 2

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,293

F3 · price: The price reported in Table I, Column 4 for sales on 8/22/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.00 to $102.63, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 21, 2019 Filed Aug 23, 2019 20:55 UTC SaleCommon Stock 4,057 $102.21 $414,673.27
Disclosure

SEC source: 0001333493-19-000135 · wf-form4_156659369171579.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,306

F1 · price: The price reported in Table I, Column 4 for sales on 8/21/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.00 to $102.63, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4) and (5) of this Form 4.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 20, 2019 Filed Aug 21, 2019 20:11 UTC
WOLF DALE BDirector
PurchaseCommon Stock 1,000 $106.20 $106,200.00
Disclosure

SEC source: 0001333493-19-000131 · wf-form4_156641825013806.xml · nonDerivative · entry 2

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,533

Read SEC document
August 19, 2019 Filed Aug 20, 2019 16:18 UTC
Hurley Robert SPresident, Carrier/Bus Dev.
Tax withholdingCommon Stock 1,860 $105.78 $196,750.80
Disclosure

SEC source: 0001333493-19-000121 · wf-form4_156633228808169.xml · nonDerivative · entry 2

Hurley Robert S · CIK 0001400991 · President, Carrier/Bus Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,838

F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 19, 2019 Filed Aug 21, 2019 20:11 UTC
WOLF DALE BDirector
PurchaseCommon Stock 1,000 $103.90 $103,895.00
Disclosure

SEC source: 0001333493-19-000131 · wf-form4_156641825013806.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,533

Read SEC document
August 19, 2019 Filed Aug 21, 2019 20:08 UTC
Flanders Scott NDirector · Chief Executive Officer
Tax withholdingCommon Stock 2,199 $105.78 $232,610.22
Disclosure

SEC source: 0001333493-19-000127 · wf-form4_156641809449574.xml · nonDerivative · entry 1

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 727,973

F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 19, 2019 Filed Aug 21, 2019 20:09 UTC
Hannan Timothy C.Chief Marketing Officer
Tax withholdingCommon Stock 1,860 $105.78 $196,750.80
Disclosure

SEC source: 0001333493-19-000129 · wf-form4_156641816587306.xml · nonDerivative · entry 1

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,710

F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation.

Read SEC document
August 19, 2019 Filed Aug 21, 2019 20:07 UTC
Francis David K.Chief Operating Officer
Tax withholdingCommon Stock 544 $105.78 $57,544.32
Disclosure

SEC source: 0001333493-19-000125 · wf-form4_156641800676426.xml · nonDerivative · entry 1

Francis David K. · CIK 0001679661 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,018

F1 · shares: Represents the withholding of shares to satisfy tax withholding obligation.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 19, 2019 Filed Aug 21, 2019 20:06 UTC
Kalin Ian JayChief Technology Officer
Tax withholdingCommon Stock 1,116 $105.78 $118,050.48
Disclosure

SEC source: 0001333493-19-000124 · wf-form4_156641795173969.xml · nonDerivative · entry 1

Kalin Ian Jay · CIK 0001733956 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,487

F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation.

Read SEC document
August 19, 2019 Filed Aug 27, 2019 22:42 UTC Amendment
Flanders Scott NDirector · Chief Executive Officer
Tax withholdingCommon Stock 1,865 $105.78 $197,279.70
Disclosure

SEC source: 0001333493-19-000142 · wf-form4a_156694575727688.xml · nonDerivative · entry 1

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 728,307

F1 · kind: This amendment is being filed to correct the number of shares withheld to satisfy tax withholding obligation.

F1 · shares: This amendment is being filed to correct the number of shares withheld to satisfy tax withholding obligation.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 16, 2019 Filed Aug 20, 2019 16:18 UTC
Hurley Robert SPresident, Carrier/Bus Dev.
Tax withholdingCommon Stock 1,550 $104.72 $162,316.00
Disclosure

SEC source: 0001333493-19-000121 · wf-form4_156633228808169.xml · nonDerivative · entry 1

Hurley Robert S · CIK 0001400991 · President, Carrier/Bus Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,698

F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 15, 2019 Filed Aug 16, 2019 20:03 UTC
Yung Derek N.SVP, Chief Financial Officer
Tax withholdingCommon Stock 2,995 $104.38 $312,618.10
Disclosure

SEC source: 0001333493-19-000119 · wf-form4_156598578986858.xml · nonDerivative · entry 1

Yung Derek N. · CIK 0001742795 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,843

F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation.

Read SEC document
August 12, 2019 Filed Aug 12, 2019 21:22 UTC
Francis David K.Chief Operating Officer
SaleCommon Stock 2,000 $109.54 $219,070.60
Disclosure

SEC source: 0001333493-19-000117 · wf-form4_156564496067283.xml · nonDerivative · entry 1

Francis David K. · CIK 0001679661 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,562

F1 · price: The price reported in Table I, Column 4 for sales on 8/12/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.525 to $109.59, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 07, 2019 Filed Aug 9, 2019 16:32 UTC
Hurley Robert SPresident, Carrier/Bus Dev.
SaleCommon Stock 1,230 $107.55 $132,284.04
Disclosure

SEC source: 0001333493-19-000115 · wf-form4_156538272960267.xml · nonDerivative · entry 3

Hurley Robert S · CIK 0001400991 · President, Carrier/Bus Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,248

F4 · price: The price reported in Table I, Column 4 for sales on 8/7/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.34 to $107.58, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 07, 2019 Filed Aug 9, 2019 16:32 UTC
Hurley Robert SPresident, Carrier/Bus Dev.
SaleCommon Stock 6,313 $107.23 $676,924.68
Disclosure

SEC source: 0001333493-19-000115 · wf-form4_156538272960267.xml · nonDerivative · entry 2

Hurley Robert S · CIK 0001400991 · President, Carrier/Bus Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,478

F3 · price: The price reported in Table I, Column 4 for sales on 8/7/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.12 to $107.24, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 07, 2019 Filed Aug 9, 2019 16:32 UTC
Hurley Robert SPresident, Carrier/Bus Dev.
SaleCommon Stock 6,770 $106.70 $722,379.99
Disclosure

SEC source: 0001333493-19-000115 · wf-form4_156538272960267.xml · nonDerivative · entry 1

Hurley Robert S · CIK 0001400991 · President, Carrier/Bus Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,791

F1 · price: The price reported in Table I, Column 4 for sales on 8/7/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.27 to $107.26, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (3) and (4) of this Form 4.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 02, 2019 Filed Aug 6, 2019 20:47 UTC
WOLF DALE BDirector
GrantCommon Stock 1,533 $0.00 $0.00
Disclosure

SEC source: 0001333493-19-000112 · wf-form4_156512444790221.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,533

F1 · kind: This represents an initial award of restricted stock units. Each unit represents a contingent right to receive one share of the company's common stock upon vesting. The restricted stock units are scheduled to vest in four equal annual installments from the vesting commencement date of August 2, 2019, subject to the individual continuing to provide services to the company through the applicable vesting date.

Read SEC document
August 01, 2019 Filed Aug 1, 2019 21:30 UTC
Hurley Robert SPresident, Carrier/Bus Dev.
SaleCommon Stock 1,500 $103.74 $155,610.00
Disclosure

SEC source: 0001333493-19-000106 · wf-form4_156470939626736.xml · nonDerivative · entry 1

Hurley Robert S · CIK 0001400991 · President, Carrier/Bus Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,061

F1 · kind: The transaction reported on this date was effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 01, 2019 Filed Aug 2, 2019 01:29 UTC SaleCommon Stock 735 $105.11 $77,255.85
Disclosure

SEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 5

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,926

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan.

F7 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.89 to $105.37, inclusive.

F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 01, 2019 Filed Aug 2, 2019 01:29 UTC SaleCommon Stock 2,000 $104.13 $208,260.00
Disclosure

SEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 4

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,661

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan.

F6 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.85 to $104.62, inclusive.

F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 01, 2019 Filed Aug 2, 2019 01:29 UTC SaleCommon Stock 2,437 $103.27 $251,668.99
Disclosure

SEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 3

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,661

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.84 to $103.78, inclusive.

F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 01, 2019 Filed Aug 2, 2019 01:29 UTC SaleCommon Stock 8,267 $102.18 $844,722.06
Disclosure

SEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 2

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,098

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.74 to $102.71, inclusive.

F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
August 01, 2019 Filed Aug 2, 2019 01:29 UTC SaleCommon Stock 1,561 $101.19 $157,961.34
Disclosure

SEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 1

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,365

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.73 to $101.74, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7) of this Form 4.

F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:17 UTC
Kalin Ian JayChief Technology Officer
Exercise / conversionStock Option (right to buy) · Derivative 5,500 $18.60 Strike: $18.60 $102,300.00
Disclosure

SEC source: 0001333493-19-000102 · wf-form4_156461864107930.xml · derivative · entry 3

Kalin Ian Jay · CIK 0001733956 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 5,500 shares

Expires 2024-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option will vest as to 25% of the shares one year after the vesting commencement date of February 27, 2017 and 1/48th of the shares each month thereafter, subject to the individual continuing to provide services to the company through the applicable vesting date.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:17 UTC
Kalin Ian JayChief Technology Officer
SaleCommon Stock 5,500 $103.00 $566,500.00
Disclosure

SEC source: 0001333493-19-000102 · wf-form4_156461864107930.xml · nonDerivative · entry 2

Kalin Ian Jay · CIK 0001733956 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,603

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:17 UTC
Kalin Ian JayChief Technology Officer
Exercise / conversionCommon Stock 5,500 $18.60 $102,300.00
Disclosure

SEC source: 0001333493-19-000102 · wf-form4_156461864107930.xml · nonDerivative · entry 1

Kalin Ian Jay · CIK 0001733956 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:13 UTC
Hannan Timothy C.Chief Marketing Officer
Exercise / conversionPerformance Stock Option · Derivative 7,500 $18.60 Strike: $18.60 $139,500.00
Disclosure

SEC source: 0001333493-19-000099 · wf-form4_156461841004038.xml · derivative · entry 9

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2024-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The performance-based stock options will be eligible to vest during a four-year performance period following the awards's grant date based on the company's stock price trading at certain pre-determined price thresholds. Once a price threshold is achieved, the portion of the award related to that threshold will vest one year later, subject to the individual continuing to provide services to the company through the applicable vesting date.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:13 UTC
Hannan Timothy C.Chief Marketing Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 7,500 $18.60 Strike: $18.60 $139,500.00
Disclosure

SEC source: 0001333493-19-000099 · wf-form4_156461841004038.xml · derivative · entry 8

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2024-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option will vest as to 25% of the shares one year after the vesting commencement date of June 26, 2017 and 1/48th of the shares each month thereafter, subject to the individual continuing to provide services to the company through the applicable vesting date.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:13 UTC
Hannan Timothy C.Chief Marketing Officer
SaleCommon Stock 100 $105.23 $10,523.00
Disclosure

SEC source: 0001333493-19-000099 · wf-form4_156461841004038.xml · nonDerivative · entry 7

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,570

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:13 UTC
Hannan Timothy C.Chief Marketing Officer
SaleCommon Stock 4,998 $104.58 $522,690.84
Disclosure

SEC source: 0001333493-19-000099 · wf-form4_156461841004038.xml · nonDerivative · entry 6

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,670

F4 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.21 to $105.17, inclusive.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:13 UTC
Hannan Timothy C.Chief Marketing Officer
SaleCommon Stock 5,587 $103.82 $580,042.34
Disclosure

SEC source: 0001333493-19-000099 · wf-form4_156461841004038.xml · nonDerivative · entry 5

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,668

F3 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.20 to $104.17, inclusive.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:13 UTC
Hannan Timothy C.Chief Marketing Officer
SaleCommon Stock 4,600 $102.72 $472,512.00
Disclosure

SEC source: 0001333493-19-000099 · wf-form4_156461841004038.xml · nonDerivative · entry 4

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,255

F2 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.17 to $103.14, inclusive.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:13 UTC
Hannan Timothy C.Chief Marketing Officer
SaleCommon Stock 4,500 $101.65 $457,425.00
Disclosure

SEC source: 0001333493-19-000099 · wf-form4_156461841004038.xml · nonDerivative · entry 3

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,855

F1 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.14 to $102.12, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) to (4) of this Form 4.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:13 UTC
Hannan Timothy C.Chief Marketing Officer
Exercise / conversionCommon Stock 7,500 $18.60 $139,500.00
Disclosure

SEC source: 0001333493-19-000099 · wf-form4_156461841004038.xml · nonDerivative · entry 2

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,355

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:13 UTC
Hannan Timothy C.Chief Marketing Officer
Exercise / conversionCommon Stock 7,500 $18.60 $139,500.00
Disclosure

SEC source: 0001333493-19-000099 · wf-form4_156461841004038.xml · nonDerivative · entry 1

Hannan Timothy C. · CIK 0001710403 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,855

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 7,500 $12.20 Strike: $12.20 $91,500.00
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · derivative · entry 11

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2020-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F10 · derivative.exercise_date: The option vested as to 100% of the shares approximately one year following the grant date. The option is scheduled to expire on 6/15/20.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
Exercise / conversionPerformance Stock Option · Derivative 92,016 $12.04 Strike: $12.04 $1,107,872.64
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · derivative · entry 10

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 92,016 shares

Expires 2024-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F9 · derivative.exercise_date: The performance-based stock option was granted in lieu of a performance-based cash bonus opportunity for 2017. The performance based stock option vested as to 92,016 shares upon compensation committee's certification of the achievement of the revenue and adjusted EBITDA goals that would have applied to Mr. Flanders' cash bonus.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
SaleCommon Stock 1,300 $106.38 $138,294.00
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · nonDerivative · entry 8

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 730,172

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F8 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.21 to $106.59, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
SaleCommon Stock 23,758 $105.53 $2,507,181.74
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · nonDerivative · entry 7

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 731,472

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F7 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.21 to $106.20, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
SaleCommon Stock 39,221 $104.81 $4,110,753.01
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · nonDerivative · entry 6

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 755,230

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F6 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.21 to $105.20, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
SaleCommon Stock 13,484 $103.81 $1,399,774.04
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · nonDerivative · entry 5

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 794,451

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F5 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.20 to $104.18, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
SaleCommon Stock 10,659 $102.71 $1,094,785.89
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · nonDerivative · entry 4

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 807,935

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F4 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.16 to $103.15, inclusive.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
SaleCommon Stock 11,094 $101.64 $1,127,594.16
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · nonDerivative · entry 3

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 818,594

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F3 · price: The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.14 to $102.13, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) to (8) of this Form 4.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,500 $12.20 $91,500.00
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · nonDerivative · entry 2

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 829,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:16 UTC
Flanders Scott NDirector · Chief Executive Officer
Exercise / conversionCommon Stock 92,016 $12.04 $1,107,872.64
Disclosure

SEC source: 0001333493-19-000101 · wf-form4_156461857266081.xml · nonDerivative · entry 1

Flanders Scott N · CIK 0001327337 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 822,188

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.

F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 00:15 UTC
Francis David K.Chief Operating Officer
SaleCommon Stock 1,000 $103.00 $103,000.00
Disclosure

SEC source: 0001333493-19-000100 · wf-form4_156461850438005.xml · nonDerivative · entry 1

Francis David K. · CIK 0001679661 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,562

F1 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.